
Indo Amines Q3 FY19 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 2
Fundraise
No
Order
Yes
Capex
Yes
2 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 2- The company expects around 30% revenue growth for the next year (FY20) on a standalone basis. (Page 4)
- Consolidated growth could be even higher than standalone. (Page 12)
- Volume growth guidance similarly expected to be around 30%. (Page 11)
- The company is working to increase capacity utilization from around 60% currently, aiming above 75%, which should improve operational performance and margins over the next 2-3 years. (Page 14)
- Incremental revenue from ongoing CAPEX (especially the new plant at Dhule) expected to impact from FY21 onward. (Pages 11-12)
- Export revenues are around 50% and are mostly denominated in USD (~95%), offering some translational gains. (Page 15)
- Future growth will be driven by product mix improvements, capacity expansion, and new product introductions targeting fine chemicals, specialty chemicals, and pharma intermediates. (Pages 10-13)
See what Indo Amines management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- There is no explicit mention of any immediate or planned new fundraising through debt or equity in the transcript.
- The company currently has a consolidated debt of around Rs. 125 crore, including Rs. 80 crore as working capital.
- They have ongoing CAPEX plans with investments around Rs. 30 crore for the current year and around Rs. 10 crore planned for the next year, totaling approximately Rs. 40 crore.
- There is no mention of raising funds through equity or debt for these CAPEX.
- On the topic of listing shares on the National Stock Exchange (NSE), the company stated they will do so once they meet the eligibility criteria, but no timeline or fundraising associated with it was provided.
- A proposed bonus issue was mentioned but currently not planned, with a possible revisit in the future.
- Overall, no specific new fundraising through debt or equity has been indicated.
See what Indo Amines management said on order book — free account, 30 seconds.
Capex plans
Yes- Ongoing CAPEX around Rs. 30 crore for a new plant at Dhule; first phase expected operational by March next year, with impact from FY21.
- Future CAPEX planned of Rs. 10 crore next year; total around Rs. 40 crore over coming year.
- CAPEX splits between debottlenecking existing capacities and new product lines, particularly pharma intermediates and fine chemicals.
- Total CAPEX for future growth, including Dhule unit, could go up to Rs. 90 crore at optimum capacity.
- Environmental investment: Rs. 2.5 to Rs. 3 crore planned over two years to upgrade Effluent Treatment Plants (ETP) to achieve zero-discharge.
- New product CAPEX aimed at value-added specialty chemicals, contingent on market conditions.
- Focus on capacity utilization improvement (currently around 60%) to enhance margins along with capacity expansions.
- CAPEX expected to contribute revenue growth and operational efficiencies from FY21 onwards.
Track Indo Amines — get its next earnings analysis in your feed
How does Indo Amines rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Indo Amines rank in Chemicals & Petrochemicals?
Compare Indo Amines against every Chemicals & Petrochemicals company (Q3 FY19) on revenue, margins and earnings-call signals.
Continue your research
What Indo Amines's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY22 earnings call analysis →
- Q4 FY19 earnings call →
- Q3 FY19 earnings call →
Earlier calls (1)
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…